Bim antibody | knockout validation | Cell Signaling 2933

This is a knockout-validated antibody summary, based on the publication "Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma", as cited below [1]. Labome curates formal publications to compile a list of antibodies with unambiguous specificity within Validated Antibody Database (VAD).

Bim antibody | knockout validation | Cell Signaling 2933 figure 1
Figure 1. Immunoblot of CRISPR Cas9 generated L363 and KMS11 BIMKO cells. From [1].
Antibody information

Company: Cell Signaling

Antibody: Bim

Catalog number: 2933

Summary: Rabbit monoclonal IgG against a synthetic peptide corresponding to residues surrounding Pro25 of Bim. Reacts with human, mouse, and rat. It is predicted to react based on 100% sequence homology with monkey, bovine, dog, and pig. Suitable for western blot, immunoprecipitation, immunohistochemistry (paraffin and Leica Bond), immunofluorescence/immunocytochemistry and flow cytometry.

Validation Method

Western blot

Sample

Control and BIM-KO L363 and KMS11 cells.

Blocking agent

5% milk in tris-buffered saline with tween TBST) for 1 h.

Primary incubation

1:1,000 dilution made in BLOK™ Casein in TBS (G-Biosciences, #786-196) overnight.

Secondary incubation

3:10,000 in blocking solution for 1 h.

References
  1. Bajpai R, Sharma A, Achreja A, Edgar C, Wei C, Siddiqa A, et al. Electron transport chain activity is a predictor and target for venetoclax sensitivity in multiple myeloma. Nat Commun. 2020;11:1228 pubmed publisher